Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 30, 2022 07:00 ET | Source: Aileron Therapeutics, Inc.

Aileron Therapeutics Regains Compliance with Nasdaq Listing Requirements

BOSTON, Nov. 30, 2022 (GLOBE NEWSWIRE) -- Aileron Therapeutics (Nasdaq: ALRN), a chemoprotection oncology company that aspires to make chemotherapy safer and thereby more effective to save more...
November 30, 2022 07:00 ET | Source: AnPac Bio-Medical Science Co., Ltd.

AnPac Announces Regaining Compliance with Nasdaq Listing Requirement

PHILADELPHIA, Nov. 30, 2022 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (Nasdaq: ANPC) (“AnPac Bio” or the “Company”), a biotechnology company with operations in the United States and...
November 30, 2022 07:00 ET | Source: TransCode Therapeutics, Inc.

TransCode Therapeutics Announces eIND Submission to US FDA for Planned First-in-Human Clinical Trial in Patients with Advanced Solid Tumors

BOSTON, Nov. 30, 2022 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, announced today...
November 30, 2022 07:00 ET | Source: View, Inc.

View, Inc. to Present at the Raymond James Technology Investors Conference

MILPITAS, Calif., Nov. 30, 2022 (GLOBE NEWSWIRE) -- View, Inc. (Nasdaq: VIEW) (“View” or the “Company”), the leader in smart building technologies, today announced that Rao Mulpuri, View’s Chief...
November 30, 2022 07:00 ET | Source: Iovance Biotherapeutics, Inc.

Iovance Biotherapeutics to Present at Upcoming Conferences

SAN CARLOS, Calif., Nov. 30, 2022 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel T cell-based cancer immunotherapies, today...
November 30, 2022 07:00 ET | Source: Sterling Infosystems, Inc

Sterling Announces New $700 Million Credit Facility and $100 Million Share Repurchase Program

Credit facility enhances capital structure and financial flexibility while reducing interest expense Share repurchase program expands capital allocation optionality and is expected to be funded...
November 30, 2022 07:00 ET | Source: Leslie’s Inc.

Leslie’s, Inc. Announces Record Results for Fourth Quarter & Fiscal 2022; Provides Fiscal 2023 Outlook

Fourth quarter and Fiscal 2022 sales increased 16.3%; Comparable sales growth of 10.2% in the fourth quarter and 10.6% in Fiscal 2022Diluted earnings per share increased 34.8% to $0.31 in the fourth...
November 30, 2022 07:00 ET | Source: Optinose, Inc.

Optinose Announces Corporate Updates and Presentation at the 34th Annual Piper Sandler Healthcare Conference

$50 Million from Recent Financing Extends Expected Cash Runway Beyond the Expected PDUFA Action Date for XHANCE as a Treatment for Chronic Sinusitis Revised Note Purchase Agreement Extends Start of...
November 30, 2022 07:00 ET | Source: First Wave BioPharma, Inc.

First Wave BioPharma Files Investigational New Drug Application for Enhanced Microgranule Delivery Formulation of Adrulipase

Upon IND clearance, Phase 2 clinical trial investigating adrulipase as a treatment for exocrine pancreatic insufficiency associated with cystic fibrosis and chronic pancreatitis is expected to...
November 30, 2022 07:00 ET | Source: B.O.S. Better Online Solutions Ltd.

B.O.S. Reports Third Quarter of the Year 2022 Financial Results

RISHON LE ZION, Israel, Nov. 30, 2022 (GLOBE NEWSWIRE) -- BOS Better Online Solutions Ltd. ("BOS" or the "Company") (NASDAQ: BOSC) reported its financial results for the third quarter of the year...